Register | Login

9
Vote
Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors, did not lead to adverse events, as some prior studies had suggested. The results were presented at the 21st annual Transcatheter Cardiovascular Therapeutics scientific symposium, sponsored by the Cardiovascular Research Foundation.
Discuss  |  Bury | 
Science

Who Voted for this Story



What is Buzz?
iLookz Buzz spotlights the latest buzz from all around the web on a single site.
Top Users


Artikel Diet  -  Buzz  -  Menurunkan Berat Badan  -  Organica Laboratories
Home  -  About iLookz  -  Privacy Policy  -  Disclaimer  -  Contact Us  -  Links
Copyright © 2009 iLookz.com - All Rights Reserved.